Single nucleotide polymorphisms in CETP, SLC46A1, SLC19A1, CD36, BCMO1, APOA5, and ABCA1 are significant predictors of plasma HDL in healthy adults

Lipids in Health and Disease

Volumn 12, Issue 1, 2013, Pages

  Clifford, Andrew J ^a   Rincon, Gonzalo ^a   Owens, Janel E ^b   Medrano, Juan F ^a   Moshfegh, Alanna J ^c   Baer, David J ^c   Novotny, Janet A ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

Cholesterol; Folate transporter; HDL; Single nucleotide polymorphism

Indexed keywords

ABC TRANSPORTER A1; ALPHA TOCOPHEROL; APOLIPOPROTEIN A5; BETA CAROTENE MONOOXYGENASE 1; CD36 ANTIGEN; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; CYANOCOBALAMIN; DNA; FOLIC ACID; HIGH DENSITY LIPOPROTEIN; PROTON COUPLED FOLATE TRANSPORTER; REDUCED FOLATE CARRIER; RETINOL; UNCLASSIFIED DRUG; UNSPECIFIC MONOOXYGENASE;

ADULT; AGED; ALLELE; ARTICLE; BODY WEIGHT; DNA EXTRACTION; FEMALE; FOLATE METABOLISM; GENDER; GENETIC ASSOCIATION; GENOTYPE; HUMAN; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PHENOTYPE; PREDICTIVE VALUE; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ANTIGENS, CD36; APOLIPOPROTEINS A; ATP BINDING CASSETTE TRANSPORTER 1; BETA-CAROTENE 15,15'-MONOOXYGENASE; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEINS; FEMALE; FOLIC ACID TRANSPORTERS; GENETIC ASSOCIATION STUDIES; HUMANS; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROTON-COUPLED FOLATE TRANSPORTER; REDUCED FOLATE CARRIER PROTEIN;

EID: 84877781008     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-12-66     Document Type: Article

References (55)

1. Systematic evaluation of environmental factors: persistent pollutants and nutrients correlated with serum lipid levels. Patel CJ, Cullen MR, Ioannidis JP, Butte AJ, Int J Epidemiol 2012 41 828 843 10.1093/ije/dys003 22421054
2. Gender and single nucleotide polymorphisms in MTHFR, BHMT, SPTLC1, CRBP2, CETP, and SCARB1 are significant predictors of plasma homocysteine normalized by RBC folate in healthy adults. Clifford AJ, Chen K, McWade L, Rincon G, Kim S-H, Holstege DM, Owens JE, Liu B, Muller H-G, Medrano JF, J Nutr 2012 142 1764 1771 10.3945/jn.112.160333 22833659
3. The G allele of transcobalamin 2 c.776C→G is associated with an unfavorable lipoprotein profile. Semmler A, Farmand S, Moskau S, Stoffel-Wagner B, Linnebank M, Ann Nutr Metab 2010 57 112 115 10.1159/000320418 20948192
4. Gene-environmental interactions reveal a homeostatic role for cholesterol metabolism during dietary folate perturbation in mice. Kitami T, Rubio R, O'Brien W, Quackenbush J, Nadeau JH, Physiol Genomics 2008 35 182 190 10.1152/physiolgenomics.00294.2007 18697859
5. CD3, CD36 Thrombospondin-4 polymorphism (A387P) predicts cardiovascular risk in postinfarction patients with high HDL cholesterol and C-reactive protein levels. Corsetti JP, Ryan D, Moss AJ, McCarthy J, Goldenberg I, Zareba W, Sparks CE, Thromb Haemost 2011 106 993 1234 10.1160/TH11-09-0677 22012630
6. Dietary cholesterol increases paraoxonase 1 enzyme activity. Kim DS, Burt AA, Ranchalis JE, Richter RJ, Marshall JK, Nakayama KS, Jarvik ER, Eintracht JF, Rosenthal EA, Furlong CE, Jarvik GP, J Lipid Res 2012 53 2450 2458 10.1194/jlr.P030601 22896672
7. Characteristics of LDL- & HDL-subclasses in pediatric renal transplant patients. Zelijkovic A, Vekic J, Spasojevic-Kalimanovska V, Jelic-Ivanovic Z, Peco-Antic A, Kostic M, Vasic D, Spasic S, Transpl Int 2011 24 1094 1102 10.1111/j.1432-2277.2011.01313.x 21848901
8. Rationale for cholesteryl ester transfer protein inhibition. Hewing B, Fisher EA, Curr Opin Lipidol 2012 23 372 376 10.1097/MOL.0b013e328353ef1d 22517614
9. Cholesteryl ester transfer protein directly mediates selective uptake of high density lipoprotein cholesteryl esters by the liver. Gauthier A, Lau P, Zha X, Milne R, McPherson R, Arterioscler Thromb Vasc Biol 2005 25 2177 2184 10.1161/01.ATV.0000183613.13929.13 16123327 (Pubitemid 41416318)
10. HDL and CETP Inhibition: Will this DEFINE the Future? Davidson MH, Curr Treatm Options Cardiovasc Med 2012 14 384 390 10.1007/s11936-012-0191-8
11. Structural basis of transfer between lipoproteins by cholesteryl ester transfer protein. Zhang L, Yan F, Zhang S, Lei D, Charles MA, Cavigiolio G, Oda M, Krauss RM, Weisgraber KH, Rye KA, Nat Chem Biol 2012 8 342 349 10.1038/nchembio.796 22344176
12. Integrated associations of genotypes with multiple blood biomarkers linked to coronary heart disease risk. Drenos TF, Talmud PJ, Casas JP, Smeeth L, Palmen J, Humphries SE, Hingorani AD, Hum Mol Genet 2009 18 2305 2316 10.1093/hmg/ddp159 19336475
13. Cholesteryl ester transfer protein TaqIB polymorphism and its association with serum lipid levels and longevity in Chinese Bama Zhuang population. Pan SL, Wang F, Lu ZP, Liu CW, Hu CY, Luo H, Peng JH, Luo XQ, Pang GF, Lu SH, Lipids Health Dis 2012 11 10.1186/1476-511X-11-26
14. Biological, clinical, and population relevance of 95 loci for blood lipids. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, Koseki M, Pirruccello JP, Ripatti S, Chasman DI, Willer CJ, Nature 2010 466 707 713 10.1038/nature09270 20686565
15. Segregation of LIPG, CETP, and GALNT2 mutations in Caucausian familesi with extremely high HDL cholesterol. Tietjen I, Hovingh GK, Singaraja RR, Radomski C, Barhdadi A, McEwen J, Chan E, Mattice M, Legendre A, Franchini PL, PLoS One 2012 7 37437 10.1371/journal.pone.0037437 22952570
16. Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk. Thompson A, Angelantonio ED, Sarwar N, Erquo S, Saleheen D, Dullart RPF, Keavney B, Ye Z, Danesh J, J Amer Med Assoc 2008 299 2777 2788 10.1001/jama.299.23.2777 (Pubitemid 351846853)
17. Four polymorphisms of cholesteryl ester transfer protein gene and coronary stenosis in a Tunisian population. Rejeb J, Omezzine A, Boumaiza I, Rebhi L, Rejeb NB, Nabli N, Abdelaziz AB, Boughzala E, Bouslama A, J Cardiovasc Med (Hagerstown) 2012 13 546 553
18. The human proton-coupled folate transporter: Biology and therapeutic applications to cancer. Desmoulin SK, Hou Z, Gangjee A, Matherly LH, Cancer Biol Ther 2012 13 1 19 10.4161/cbt.13.1.18438 22198566
19. Plasma folate levels are associated with the lipoprotein profile: a retrospective database analysis. Semmler A, Moskau S, Grigull A, Farmand S, Klockgether T, Smulders YM, Blom HJ, Zur B, Stoffel-Wagner B, Linnebank M, Nutr J 2010 9 31 34 10.1186/1475-2891-9-31 20667074
20. Dynamics of antifolate transport via the reduced folate carrier and the membrane folate receptor in murine leukaemia cells in vitor and in vivo. Mauritz R, Peters GJ, Kathmann I, Teshale H, Noordhuis P, Comijn EM, Pinedo HM, Jansen G, Cancer Chemother Pharmacol 2008 62 937 948 10.1007/s00280-008-0683-0 18283461
21. Measures of adiposity and body fat distribution in relation to serum folate levels in postmenopausal women in a feeding study. Mahabir S, Ettinger S, Johnson L, Baer DJ, Clevidence BA, Hartman TJ, Taylor PR, Eur J Clin Nutr 2008 62 644 650 10.1038/sj.ejcn.1602771 17457338 (Pubitemid 351663404)
22. Fetal serum folate concentrations and placental folate transport in obese women. Carter MF, Powell TL, Li C, Myatt L, Dudley D, Nathanielsz P, Jansson T, Am J Obstet Gynecol 2011 205 83.e17 83.e25 10.1016/j.ajog.2011.02.053
23. Polymorphism of the CD36 gene and cardiovascular risk factors in patients with coronary artery disease manifested at a young age. Rac ME, Suchy J, Kurzawski G, Kurlapska A, Safranow K, Rac M, Sagasz-Tysiewicz D, Krzystolik A, Poncyljusz W, Jakubowska K, Biochem Genet 2012 50 103 111 10.1007/s10528-011- 9475-z 22113854
24. Association of polymorphisms in platelet and hemostasis system genes with acute myocardial infarction. Knowles JW, Wang H, Itakura H, Southwick A, Myers RM, Iribarren C, Fortmann SP, Go AS, Quertermous T, Hlatky MA, Am Heart J 2007 154 1052 1058 10.1016/j.ahj.2007.05.021 18035074 (Pubitemid 350116028)
25. Variants in the CD36 gene locus determine whole-body adiposity, but have no independent effect on insulin sensitivity. Heni M, Mussing K, Machicao F, Machann J, Schick F, Claussen CD, Stefan N, Fritsche A, Haring HU, Staiger H, Obesity 2011 19 1004 1009 10.1038/oby.2010.251 20966915
26. Common sequence variants in CD36 gene and the levels of triglyceride and high-density lipoprotein cholesterol among ethnic Chinese in Taiwan. Chien KL, Hsu HC, Liu PH, Lin HJ, Chen MF, Lipids Health Dis 2012 11 10.1186/1476-511X-11- 174
27. Common variation in the beta-carotene 15,15'-monooxygenase 1 gene affects circulating levels of carotenoids: a genome-wide association study. Ferrucci L, Perry JR, Matteini A, Perola M, Tanaka T, Silander K, Rice N, Melzer D, Murray A, Cluett C, Am J Hum Genet 2009 84 123 133 10.1016/j.ajhg.2008.12.019 19185284
28. New findings on apo-carotenoid metabolites of B-carotene. Wang CX, Wongsiriroj N, Deckelbaum RJ, Blaner WS, Harrison EH, Sight and Life 2012 26 18 27
29. Single nucleotide polymorphisms upstream from the β-carotene 15,15'-monoxygenase gene influence provitamin A conversion efficiency in female volunteers. Lietz G, Oxley A, Leung W, Hesketh J, J Nutr 2012 142 161S 165S 10.3945/jn.111.140756 22113863
30. Hruszkewycz DP, dela Sena C, Narayanasamy S, Riedl KM, Kopec RE, Schwartz SJ, Curley RWJ, Harrison EH: Naturally occuring eccentric cleavage products of provitamin A B-carotene function as antagonists of retinoic acid receptors. Eroglu A, J Biol Chem 2012 287 15886 15895 10.1074/jbc.M111.325142 22418437
31. dela Sena C, Eroglu A, Fleshman MK: The formation, occurrence, and function of B-apocarotenoids: B-carotene metabolites that may modulate nuclear receptor signaling. Harrison EH, Am J Clin Nutr 2012 96 1189S 1192S 10.3945/ajcn.112.034843 23053561
32. Circulating beta-carotene levels and type 2 diabetes-cause or effect? Perry JR, Ferrucci L, Bandinelli S, Guralnik J, Semba RD, Rice N, Melzer D, Saxena R, Scott LJ, McCarthy MI, Diabetologia 2009 52 2117 2121 10.1007/s00125-009-1475-8 19662379
33. Associations of polymorphisms in the apolipoprotein A1/C3/A4/A5 gene cluster with familial combined hyperlipidaemia in Hong Kong Chinese. Liu ZK, Hu M, Baum L, Thomas GN, Tomlinson B, Atherosclerosis 2010 208 427 432 10.1016/j.atherosclerosis.2009.08.013 19732897
34. Apolipoprotein A1/C3/A5 haplotypes and serum lipid levels. Yin RX, Li Y-Y, Lai C-Q, Lipids Health Dis 2011 10 1 16 10.1186/1476-511X-10-1 21733182
35. Association of apolipoprotein A5 gene polymorphisms and serum lipid levels. Li Y-Y, Yin RX, Lai C-Q, Li M, Long X-J, Li K-L, Liu W-Y, Zhang L, Wu J-Z, Nutr Metab Cardivasc Dis 2011 21 947 956 10.1016/j.numecd.2010.04.004
36. Mechanism of ATP-binding cassette transporter A1-mediated cellular lipid efflux to apolipoprotein A-1 and formation of high density lipoprotein particles. Vedhachalam C, Duong PT, Nickel M, Nguyen D, Dhanasekaran P, Saito H, Rothblat GH, Lund-Katz S, Phillips MC, J Biol Chem 2007 282 25123 25130 10.1074/jbc.M704590200 17604270 (Pubitemid 47347535)
37. ATP-binding cassette A1-mediated lipidation of apolipoprotein A-1 occurs at the plasma membrane and not in the endocytic compartments. Denis M, Landry YD, Zha X, J Biol Chem 2008 283 16178 16186 10.1074/jbc.M709597200 18385134
38. Polymorphism in ABCA1 influences CSF 24S-hydroxycholesterol levels but is not a major risk factor of Alzheimer's disease. Kolsch H, Lutjohann D, Jessen F, Von Bergmann K, Schmitz S, Urbach H, Maier W, Heun R, Int J Mol Med 2006 17 791 794 16596262
39. Nascent high density lipoproteins formed by ABCA1 resemble lipid rafts and are structurally organized by three apoA-1 monomers. Sorci-Thomas MG, Owen JS, Fulp B, Bhat S, Zhu X, Parks JS, Shah D, Jerome WG, Gerelus M, Zabalawi M, Thomas MJ, J Lipid Res 2012 53 1890 1909 10.1194/jlr.M026674 22750655
40. ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. Kennedy MA, Barrera GC, Nakamura K, Baldan A, Tarr P, Fishbein MC, Frank J, Francone OL, Edwards PA, Cell Metab 2005 1 121 131 10.1016/j.cmet.2005.01.002 16054053 (Pubitemid 43977167)
41. Exome sequencing identifies two rare variants for low HDL-C in an extended family. Linga Reddy MV, Iatan I, Weissglas-Volkov D, Nikkola E, Haas BE, Juvonen M, Ruel I, Sinsheimer JS, Genest J, Pajukanta P, Circ Cardiovasc Genet 2012 5 538 546 10.1161/CIRCGENETICS.112.963264 22923419
42. Retinoic acid receptor agonists regulate expression of ATP-binding cassette transporter G1 in macrophages. Ayaori M, Yakushjii E, Ogura M, Nakaya K, Hisada T, Uto-Kondo H, Takiguchi S, Terao Y, Sasaki M, Komatsu T, Biochim Biophys Acta 1821 2012 561 572
43. Lack of Abcg1 results in decreased plasma HDL cholesterol levels and increased biliary cholesterol secretion in mice fed a high cholesterol diet. Wiersma H, Nijstad N, de Boer JF, Out R, Hogewerf W, van Berkel TJ, Kuipers F, Tietge UJ, Atherosclerosis 2009 206 141 147 10.1016/j.atherosclerosis.2009.02. 022 19339012
44. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Bodzioch M, Orso E, Klucken J, Langmann T, Bottcher A, Diederich W, Drobnik W, Barlage S, Buchler C, Porsch-Ozcurumez M, Nat Genet 1999 22 347 351 10.1038/11914 10431237 (Pubitemid 29369524)
45. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficienc. Brooks-Wilson A, Marcil M, Clee SM, Zhang L-H, Roomp K, van Dam M, Brewer C, Collins JA, Molhuizen HOF, Loubser O, Nat Genet 1999 22 336 345 10.1038/11905 10431236 (Pubitemid 29369523)
46. ABCA1 single nucleotide polymorphisms on high-density lipoprotein-cholesterol and overweight: the D.E.S.I.R. study. Porchay I, Pean F, Bellili N, Royer B, Cogneau J, Chesnier M-C, Caradec A, Tichet J, Balkau B, Marre M, Fumeron F, Obesity 2006 14 1874 1879 10.1038/oby.2006.217 17135600 (Pubitemid 46127363)
47. Common ABCA1 variants, HDL levels, and cellular cholesterol efflux in subjects with familial low HDL. Soro-Paavonen A, Naukkarinen J, Lee-Rueckert M, Watanabe H, Rantala E, Soderlund S, Hiukka A, Kovanen PT, Jauhianen M, Peltonen L, Taskinen M-R, J Lipid Res 2007 48 1409 1416 10.1194/jlr.P600012-JLR200 17372331 (Pubitemid 47312044)
48. Common and rare ABCA1 variants affecting plasma HDL cholesterol. Wang J, Burnett JR, Near S, Young K, Zinman B, Hanley AJG, Connelly PW, Harris SB, Hegele RA, Arterioscler Thromb Vasc Biol 2000 20 1983 1989 10.1161/01.ATV.20.8. 1983 10938021 (Pubitemid 30644649)
49. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Voight BF, Peloso GM, Orho-Melander M, Frikke-Schmidt R, Barbalic M, Jensen MK, Hindy G, Hólm H, Ding EL, Johnson T, Lancet 2012 380 572 580 Erratum in: Lancet, 2012 Aug 2011;2380(9841):2564 10.1016/S0140-6736(12)60312-2 22607825
50. Freark de Boer J, Gautier T, Rensen PC, Rader DJ, Tietge UJ: ApoE promotes hepatic selective upatke but not RCT due to increased ABCA1-mediated cholesterol efflux to plasma. Annema W, Dikkers A, J Lipid Res 2012 53 929 940 10.1194/jlr.M020743 22383685
51. Niacin increases HDL biogenesis by enhancing DR4-dependent transcription of ABCA1 and lipidation of apolipoprotein A-1 in HepG2 cells. Zhang LH, Kamanna VS, Ganji SH, Xiong XM, Kashyap ML, J Lipid Res 2012 53 941 950 10.1194/jlr.M020917 22389325
52. The US Department of Agricultur Automated Multiple-Pass Method reduces bias in the collection of energy intakes. Moshfegh AJ, Rhodes DG, Baer DJ, Murayi T, Clemens JC, Rumpler WV, Paul DR, Sebastian RS, Kuczynksi KJ, Ingwersen LA, Am J Clin Nutr 2008 88 324 332 18689367
53. dbSNP Home Page: Short Genetic Variations http://www.ncbi.nlm.nih.gov/ projects/SNP/; Last accessed 06/21/2012
54. e!Ensembl http://uswest.ensembl.org/index.html; Last accessed 06/21/2012
55. A direct approach to false discovery rates. Storey J, J R Statist Soc 2002 B 64 479 498